First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020
Weekly / June 12, 2020 / 69(23);710–713
On June 8, 2020, this report was posted online as an MMWR Early Release.
Alexandra Newman, DVM1; David Smith, DVM2; Ria R. Ghai, PhD3,4; Ryan M. Wallace, DVM3,4; Mia Kim Torchetti, DVM, PhD5; Christina Loiacono, DVM, PhD5; Laura S. Murrell, MA3,4; Ann Carpenter, DVM3,4; Scott Moroff, VMD6; Jane A. Rooney, DVM7; Casey Barton Behravesh, DVM, DrPH3,4 (View author affiliations)View suggested citation
What is already known about this topic?
A small number of companion animals worldwide have been naturally infected with SARS-CoV-2, the virus that causes COVID-19.
What is added by this report?
Two domestic cats with respiratory illnesses lasting 8 and 10 days are the first reported companion animals with SARS-CoV-2 infection in the United States. Both cats were owned by persons with suspected or confirmed COVID-19, and both cats fully recovered.
What are the implications for public health practice?
Human-to-animal transmission of SARS-CoV-2 can occasionally occur. Animals are not known to play a substantial role in spreading COVID-19, but persons with COVID-19 should avoid contact with animals. Companion animals that test positive for SARS-CoV-2 should be monitored and separated from persons and other animals until they recover.
Views equals page views plus PDF downloads
On April 22, CDC and the U.S. Department of Agriculture (USDA) reported cases of two domestic cats with confirmed infection with SARS-CoV-2, the virus that causes coronavirus disease 2019 (COVID-19). These are the first reported companion animals (including pets and service animals) with SARS-CoV-2 infection in the United States, and among the first findings of SARS-CoV-2 symptomatic companion animals reported worldwide. These feline cases originated from separate households and were epidemiologically linked to suspected or confirmed human COVID-19 cases in their respective households. Notification of presumptive positive animal test results triggered a One Health* investigation by state and federal partners, who determined that no further transmission events to other animals or persons had occurred. Both cats fully recovered. Although there is currently no evidence that animals play a substantial role in spreading COVID-19, CDC advises persons with suspected or confirmed COVID-19 to restrict contact with animals during their illness and to monitor any animals with confirmed SARS-CoV-2 infection and separate them from other persons and animals at home (1).
SARS-CoV-2 is a zoonotic coronavirus that likely originated in bats (2). A small number of animals worldwide, including dogs, cats, zoo tigers and lions, and farmed mink, have been infected naturally with SARS-CoV-2, mostly through suspected human-to-animal transmission† (3). In addition, experimental studies in ferrets, golden Syrian hamsters, Egyptian fruit bats, and cats show that these species can transmit infection to cohoused animals of the same species (4–7).
On March 24, in Nassau County, New York, a 4-year-old male domestic shorthair (cat A), developed respiratory illness characterized by sneezing, clear ocular discharge, and mild lethargy (Figure). On April 1, the cat was taken to a veterinary clinic; on physical examination the cat was found to be overweight, with a normal body temperature (101.4°F [38.6°C]). Nasal, oropharyngeal, and ocular swabs were collected by veterinary staff members and submitted to a private diagnostic laboratory (laboratory A) for a routine feline respiratory polymerase chain reaction (PCR) panel designed to detect Mycoplasma felis, Bordetella bronchiseptica, feline calicivirus, Chlamydophila felis, feline herpesvirus, and influenza A H1N1pdm. A broad-spectrum cephalosporin class antibiotic (cefovecin; 52 mg) was administered subcutaneously, and the cat was returned home, where it fully recovered by April 3. Results of the routine feline respiratory panel were negative for all pathogens and the specimen was tested using a SARS-CoV-2 reverse transcription PCR (RT-PCR) diagnostic assay as part of laboratory A’s passive COVID-19 pet surveillance program.
On April 1, in Orange County, New York, a 5-year-old female Devon Rex (cat B), developed respiratory illness including sneezing, coughing, watery nasal and ocular discharge, loss of appetite, and lethargy. On April 6, the owner, an employee at a Connecticut veterinary clinic, collected conjunctival, nasal, deep oral, and fecal specimens from cat B in the home using sterile culturettes. These specimens also were sent to laboratory A and tested using the feline respiratory PCR panel. Cat B fully recovered by April 8 without treatment. At laboratory A, the feline respiratory PCR panel had a positive result for Mycoplasma felis and negative results for other common feline respiratory pathogens. The specimens from cat B also were tested by laboratory A for SARS-CoV-2.
On April 14, laboratory A reported a positive SARS-CoV-2 RT-PCR result for cat A to the USDA National Veterinary Services Laboratories (NVSL), veterinary clinic, and New York state veterinarian, who immediately notified the New York State Department of Health (NYSDH). The same day, laboratory A notified NVSL and Connecticut state animal health officials of the positive SARS-CoV-2 RT-PCR result for cat B. After determining that cat B resided in New York, the New York state veterinarian was informed, and the NYSDH was immediately notified. RNA from the positive respiratory specimens from both cat A and cat B were forwarded from laboratory A to NVSL for confirmatory testing.
On April 14, following notification of presumptive positive SARS-CoV-2 test results for cats A and B, state and federal partners conducted a joint epidemiologic investigation. Household members and veterinarians who had treated the infected cats were questioned regarding the cats’ living arrangements, health condition, potential sources of infection, and risks posed by these animals to other animals inside and outside the home, and to humans.
Cat A lived in an apartment with five persons, including three who had shown signs of mild respiratory illness including fever, cough, and sweating; none of the five were tested for SARS-CoV-2 infection. The first person’s illness began around March 15, 9 days before cat A became ill, and lasted <48 hours. Residents of the household’s apartment complex also experienced multiple cases of human COVID-19 around the same time. A second cat in the household, a 3-year-old female domestic shorthair, remained healthy and was not tested for SARS-CoV-2. Both cats were typically kept indoors but did occasionally venture outside.
Cat B lived in a single-family home with one person, who developed fever, productive cough, chills, muscle aches, abdominal pain, headache, diarrhea, sore throat, and fatigue on March 24, 8 days before cat B became ill. Specimens collected from this person on March 26 for viral testing were positive for SARS-CoV-2. By March 27, the illness had resolved. A second cat in the household, a 7-year-old Devon Rex, remained healthy and was not tested for SARS-CoV-2. Both cats were kept exclusively indoors.
On April 17, state and local One Health partners collected additional specimens from cats A and B for confirmatory diagnosis of SARS-CoV-2 at NVSL (Table). Real-time RT-PCR, using a modified CDC N-target assay and sequencing (8), determined that results for both cat A and B were positive at the first specimen collections (April 1 and 6, respectively), and the nasal swab from cat A was weakly positive from the subsequent collection (April 17). Both cats had SARS-CoV-2–specific virus neutralizing antibodies, but virus isolation in cell culture from subsequent specimen collection was unsuccessful for both cats, likely due to virus clearance. Cat A and B recovered from illness 11 days and 6 days before initiation of the epidemiologic investigation; therefore, no additional monitoring or infection prevention measures were recommended.
An estimated 76 million pet cats live in the United States, and approximately 70% of U.S. households own at least one pet (9). Close interactions between humans and pets create opportunities for zoonotic disease transmission. In both cases presented in this report, the cats with positive test results for SARS-CoV-2 had close epidemiologic links to owners with suspected or confirmed COVID-19. In addition, human symptom onset preceded that in cat A by 9 days and in cat B by 8 days. No identified onward human or animal infections were attributed to these animals. This evidence supports findings to date that animals do not play a substantial role in spreading SARS-CoV-2, although human-to-animal transmission can occur in some situations. Companion animals that test positive for SARS-CoV-2 should be monitored and separated from persons and other animals until they recover.
Both animals in this report were initially tested by laboratory A as part of a passive COVID-19 pet surveillance program that operated independently from state and federal health agencies. This method of surveillance was unable to routinely obtain epidemiologic information regarding SARS-CoV-2 exposures before testing. CDC and USDA have identified four situational testing categories§ (10); one of the four categories recommends testing symptomatic animals with close contact to a person with suspected or confirmed COVID-19. Epidemiologic investigation conducted after positive SARS-CoV-2 test results were reported found that both cat A and cat B fit this situational category.
Currently, CDC and USDA recommend that epidemiologic information be collected before companion animal SARS-CoV-2 testing, and that the decision to test animals be coordinated with state public health veterinarians and state animal health officials using a One Health approach, to ensure that animal and public health responses occur in a timely and effective manner. Laboratory A’s passive surveillance program operated for a limited period to better understand the impact of SARS-CoV-2 on animals at risk for infection and did not divert resources necessary to conduct human SARS-CoV-2 testing, consistent with CDC and USDA guidance.
Establishment of the U.S. One Health Federal Interagency COVID-19 Coordination Group (OHFICCG) in February 2020, and routine communication between state and federal One Health partners have been instrumental in ensuring a coordinated government response to the One Health aspects of COVID-19. This One Health coordination platform allows for collaboration and rapid information-sharing across sectors while also facilitating alignment of research, priorities, and messaging regarding the human, animal, and environmental aspects of COVID-19. Laboratory A, state partners, and members of OHFICCG coordinated information sharing during this investigation. Information from this investigation informed OHFICCG guidance development for managing SARS-CoV-2–infected animals, including guidance for when animals with positive test results should resume normal activities. This investigation provides further support for the utility of a One Health approach to addressing zoonotic diseases such as COVID-19 to safeguard the health, welfare, and safety of humans, animals, and their shared environment.
Members of cat A and cat B households; veterinary clinics in New York state and Connecticut; laboratory A; officials from the New York State Department of Health, New York State Department of Agriculture and Markets, and Connecticut Department of Agriculture; U.S. Department of Agriculture One Health Coordination and National Veterinary Services Laboratories staff members; staff members from CDC’s COVID-19 One Health Working Group.
Corresponding author: Casey Barton Behravesh, CBartonbehravesh@cdc.gov, 404-639-0367.
1New York State Department of Public Health; 2New York State Department of Agriculture and Markets; 3COVID-19 One Health Working Group, CDC; 4National Center for Emerging and Zoonotic Infectious Diseases, CDC; 5National Veterinary Services Laboratories, Animal and Plant Health Inspection Service (APHIS), U.S. Department of Agriculture (USDA); 6Antech Diagnostics; 7One Health Coordination, APHIS, USDA.
All authors have completed and submitted the International Committee of Medical Journal Editors form for disclosure of potential conflicts of interest. David Smith reports grants and nonfinancial support from the USDA Animal and Plant Health Inspection Service, Veterinary Services, during the conduct of the study. No other potential conflicts of interest were disclosed.
* One Health is a collaborative, multisectoral, and transdisciplinary approach, working at the local, regional, national, and global levels, with the goal of achieving optimal health outcomes recognizing the interconnection between humans, animals, plants, and their shared environment.
§ Testing is indicated for four situational categories: 1) Animals with clinical signs of illness consistent with SARS-CoV-2 infection and an epidemiologic link to a person with suspected or confirmed COVID-19; 2) Animals with clinical signs of illness consistent with SARS-CoV-2 infection and an epidemiologic link to an environment that is at high risk for SARS-CoV-2 contamination; 3) Threatened, endangered, or otherwise imperiled or rare animals in a rehabilitation or zoologic facility with possible exposure to SARS-CoV-2 through an infected person or animal; 4) Animals in a mass care or group setting where a cluster of animals shows clinical signs of illness consistent with SARS-CoV-2.
- CDC. Pets and other animals. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/animals/pets-other-animals.html
- Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020;26:450–2. CrossRefexternal icon PubMedexternal icon
- Sit THC, Brackman CJ, Ip SM, et al. Infection of dogs with SARS-CoV-2. Nature 2020. CrossRefexternal icon PubMedexternal icon
- Shi J, Wen Z, Zhong G, et al. Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS-coronavirus 2. Science 2020;368:1016–20. CrossRefexternal icon PubMedexternal icon
- Chan JF-W, Zhang AJ, Yuan S, et al. Simulation of the clinical and pathological manifestations of coronavirus disease 2019 (COVID-19) in golden Syrian hamster model: implications for disease pathogenesis and transmissibility. Clin Infect Dis 2020;ciaa325. CrossRefexternal icon PubMedexternal icon
- Rockx B, Kuiken T, Herfst S, et al. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020;368:1012–5. CrossRefexternal icon PubMedexternal icon
- Schlottau K, Rissmann M, Graaf A, et al. Experimental transmission studies of SARS-CoV-2 in fruit bats, ferrets, pigs and chickens [Preprint]. The Lancet Microbe 2020. https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3578792external icon
- Wang L, Mitchell PK, Calle PP, et al. Complete genome sequence of SARS-CoV-2 in a tiger from a U.S. zoological collection. Microbiol Resour Announc 2020;9:e00468–20. CrossRefexternal icon PubMedexternal icon
- American Pet Products Association. 2019–2020 APPA National Pet Owners Survey. Stamford, CT: American Pet Products Association; 2019.
- CDC. Evaluation for SARS-CoV-2 testing in animals. Atlanta, GA: US Department of Health and Human Services, CDC; 2020. https://www.cdc.gov/coronavirus/2019-ncov/php/animal-testing.html
FIGURE. Timeline of events related to SARS-CoV-2 infections in two domestic cats (cats A and B) kept as pets in two different households — New York, March 15–April 22, 2020
Abbreviations: COVID-19 = coronavirus disease 2019; USDA NVSL = United States Department of Agriculture National Veterinary Services Laboratories.
Suggested citation for this article: Newman A, Smith D, Ghai RR, et al. First Reported Cases of SARS-CoV-2 Infection in Companion Animals — New York, March–April 2020. MMWR Morb Mortal Wkly Rep 2020;69:710–713. DOI: http://dx.doi.org/10.15585/mmwr.mm6923e3external icon.
MMWR and Morbidity and Mortality Weekly Report are service marks of the U.S. Department of Health and Human Services.
Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.
References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.
All HTML versions of MMWR articles are generated from final proofs through an automated process. This conversion might result in character translation or format errors in the HTML version. Users are referred to the electronic PDF version (https://www.cdc.gov/mmwr) and/or the original MMWR paper copy for printable versions of official text, figures, and tables.
Questions or messages regarding errors in formatting should be addressed to email@example.com.